Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitric oxide synthase type I/nNOS catalyzes NO production from L‑arginine using multiple cofactors through a dimeric structure requiring calcium/calmodulin for activation. It plays essential roles primarily within neural tissues but impacts broader physiological processes including blood flow regulation and immune modulation. Dysfunctional nNOS activity contributes to several disease states via altered NO signaling pathways.
Inhibition of nitric oxide production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide synthase type I (nNOS).